Bringing the fundamentals into focus…
Back to Enliven Therapeutics, Inc.
How Enliven Therapeutics, Inc. stacks up
ELVN · against 309 other Healthcare companies of similar size
Profitability
26/ 100
Near the bottom of its peers.
Ranked #237 of 310 · scores higher than 23% of peers
Bars: peers in each 10-point band of the profitability score28 peers with a profitability score of 20–29, including ELVN · Click a bar to see the companies
Why profitability scores 26?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets and return on invested capital, which are weaker than most Healthcare peers.
- a lower return on assets: weaker than 76% of peers. Return on assets: -11.6% vs peer median 1.7%
- a lower return on invested capital: weaker than 76% of peers. Return on invested capital: -12.9% vs peer median 4.7%
- Operating margin is not reported, so it is left out of the score.
Metric by metric
Position: dot = ELVN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ELVN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 299 reported | -12.9% | 7.3% | 23% | 33% | |
| Operating marginHigher is better · 286 reported | Not reported | 9.7% | — | — | 33% |
| Return on assetsHigher is better · 293 reported | -11.6% | 2.6% | 22% | 33% | |
| Return on equityHigher is better · 287 reported | -15.3% | 6.9% | 27% | Context only | |
| Gross marginHigher is better · 317 reported | 0.0% | 49.1% | 3% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around ELVN| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 4 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 4 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 234 | 6.0B USD | 28 | 30 | |
| 234 | 3.4B USD | 28 | 48 | |
| 237 | 12.1B CNY (≈$1.7B) | 26 | 15 | |
| 237 | 6.1B USD | 26 | ||
| 237 | 3.3B USD | 26 | 44 | |
| 240 | 4.1B USD | 25 | 39 | |
| 240 | 5.6B USD | 25 | 53 | |
| 240 | 1.9B USD | 25 | 44 | |
| 240 | 2.0B USD | 25 | 53 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score